Study Stopped
Insufficient subject recruitment
Study to Validate a Computerized Neuropsychological Test Battery
Reliability and Validity of Umea Computerized Neuropsychological Battery
1 other identifier
observational
1
1 country
1
Brief Summary
This study is comparing a new computer-based method of administering neuropsychological tests to the standard method of verbal and paper/pencil tests administered in person by an examiner. The purpose of the research is to determine if the computerized and standard testing methods are equivalent.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2011
CompletedFirst Posted
Study publicly available on registry
August 22, 2011
CompletedStudy Start
First participant enrolled
September 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedApril 1, 2015
March 1, 2015
2 years
August 19, 2011
March 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Computer Hydrocephalus Neuropsychological Assessment Versions 1 & 2
Within 2-5 weeks of enrollment
Standard Hydrocephalus Neuropsychological Assessment: Versions 1 & 2
Within 2-5 weeks of enrollment
Eligibility Criteria
Healthy elderly subjects without significant neurologic, psychiatric, cardiovascular, or other systemic disease that impairs neurologic function or cognitive function
You may qualify if:
- Age 60-80
You may not qualify if:
- Neurological disorder that results in motor or cognitive dysfunction
- Perceptual or motor difficulties that would prevent subjects from taking the assessment
- MMSE score \<20
- MoCA score \<26
- MAS score \>9
- Significant abnormal neurologic examination findings
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sandra and Malcolm Berman Brain & Spine Institute
Baltimore, Maryland, 21209, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Michael A Williams, MD
LifeBridge Health
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Director, Sandra and Malcolm Berman Brain & Spine Institute
Study Record Dates
First Submitted
August 19, 2011
First Posted
August 22, 2011
Study Start
September 1, 2011
Primary Completion
September 1, 2013
Study Completion
December 1, 2013
Last Updated
April 1, 2015
Record last verified: 2015-03